| Axon ID |
Name |
Description |
From price |
|
1136
|
SU 6656
|
SRC kinase inhibitor |
€120.00 |
|
1392
|
Dasatinib
|
Bcr-Abl and Src tyrosine kinase inhibitor |
€90.00 |
|
1407
|
SKI 606
|
Bcr-Abl and Src tyrosine kinase inhibitor |
€75.00 |
|
1456
|
AZD0530 difumarate
|
Inhibitor of SRC and ABL tyrosine kinases |
€70.00 |
|
1698
|
A 770041
|
Orally active src-family selective lck inhibitor |
€140.00 |
|
1941
|
MLR 1023
|
Selective allosteric activator of Lyn kinase |
€95.00 |
|
2097
|
CGP 77675
|
Src Family kinase (SFK) inhibitor |
€65.00 |
|
2366
|
NG 25 trihydrochloride
|
Type II inhibitor of TAK1 (MAP3K7) and MAP4K2 (GCK) |
€75.00 |
|
2381
|
WH-4-023
|
Orally active src-family selective lck inhibitor |
€90.00 |
|
2560
|
Tilfrinib
|
Brk inhibitor with antiproliferative activity in breast tumor cells |
€95.00 |
|
2695
|
NSC 23005 sodium
|
Novel small molecule inhibitor of INK4C (p18(INK4C) or p18) |
€90.00 |
|
2778
|
Squarunkin A
|
Selective UNC119–cargo interaction inhibitor |
€125.00 |
|
3134
|
AZD6738
|
Potent, selective, orally active and bioavailable ATR kinase inhibitor |
€110.00 |
|
3284
|
Saracatinib
|
Inhibitor of SRC and ABL tyrosine kinases |
€70.00 |
|
3184
|
SR-4835
|
Potent, highly selective and orally bioavailable dual CDK12/CDK13 inhibitor |
€130.00 |
|
3165
|
Lenvatinib
|
Multi-targeted receptor tyrosine kinase inhibitor |
€70.00 |
|
3270
|
Lj-1-60
|
Fyn inhibitor targeting the Fyn/Stat3 pathway |
€90.00 |
|
3228
|
CDK inhibitor CR8
|
Potent CDK inhibitor (1, 2, 5, 7, and 9 specific) |
€130.00 |
|
3407
|
LOXO-101 sulfate
|
First-in-class, potent, highly selective and ATP-competitive TRK inhibitor |
€80.00 |
|
3402
|
THZ531
|
First-in-class, potent, selective, covalent CDK12/CDK13 inhibitor |
€130.00 |
|
3099
|
TL02-59
|
Potent, selective and orally active Fgr and Lyn inhibitor |
€120.00 |
|
3775
|
TrkB agonist prodrug R13
|
Prodrug of 7,8-Dihydroxyflavone; TrkB agonist |
€120.00 |
|
3901
|
LOXO-195
|
Trk inhibitor |
Inquire |
|
3973
|
XL-228
|
Multitargeted protein kinase inhibitor (IGF1R, Aurora,FGFR, ABL,ALK and SRC) |
Inquire |
|
3998
|
MGCD516
|
Orally bioavailable receptor tyrosine kinase (RTK) inhibitor |
Inquire |
|
4010
|
BLK degrader compound 9
|
First potent and highly selective monomeric degrader of B-lymphoid tyrosine kinase (BLK) |
€180.00 |
|
3525
|
ETP-47799
|
Potent CDK8/CDK19 inhibitor |
€90.00 |